Sleep outcomes in spinal muscular atrophy and role of disease-modifying treatments.
D. Butler (London, United Kingdom), I. Makariou (London, United Kingdom), M. Scoto (London, United Kingdom), V. Gowda (London, United Kingdom), M. Fernandez (London, United Kingdom), E. Wraige (London, United Kingdom), H. Jungbluth (London, United Kingdom), F. Muntoni (London, United Kingdom), H. Tan (London, United Kingdom), F. Trucco (London, United Kingdom)
Source: International Congress 2022 – Paediatric sleep disorders and management in various diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Butler (London, United Kingdom), I. Makariou (London, United Kingdom), M. Scoto (London, United Kingdom), V. Gowda (London, United Kingdom), M. Fernandez (London, United Kingdom), E. Wraige (London, United Kingdom), H. Jungbluth (London, United Kingdom), F. Muntoni (London, United Kingdom), H. Tan (London, United Kingdom), F. Trucco (London, United Kingdom). Sleep outcomes in spinal muscular atrophy and role of disease-modifying treatments.. 270
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|